Analysis of host gene expression profile in HIV-1 and HIV-2 infected T-cells

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Devadas, Krishnakumar ^a   Biswas, Santanu ^a   Haleyurgirisetty, Mohan ^a   Wood, Owen ^a   Ragupathy, Viswanath ^a   Lee, Sherwin ^a   Hewlett, Indira ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AARS GENE; ABCG5 GENE; ACAT2 GENE; ACIN1 GENE; ACOT7 GENE; AGPAT2 GENE; AKT2 GENE; APOA1 GENE; APOC1 GENE; APOPTOSIS; ARTICLE; ATF3 GENE; B LYMPHOCYTE ACTIVATION; CANX GENE; CBS GENE; CCL5 GENE; CEL GENE; CELL METABOLISM; CONTROLLED STUDY; CRNDE GENE; CYP51A1 GENE; DHCR24 GENE; DHCR7 GENE; DLG1 GENE; DOWN REGULATION; E2F3 GENE; EBP GENE; FADS1 GENE; FADS2 GENE; FDPS GENE; FOS GENE; FXYD2 GENE; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GRB10 GENE; H1F0 GENE; HIVEP3 GENE; HLA DOA GENE; HNRNPA1 GENE; HNRNPA1L2 GENE; HSP90AA1 GENE; HSPA1B GENE; HSPA6 GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; ICAM1 GENE; IL10 GENE; IL13 GENE; IL15RA GENE; IL4 GENE; IL5 GENE; IL6 GENE; IMMUNOCOMPETENT CELL; KIAA0125 GENE; KRT1 GENE; LAIR2 GENE; LYMPHOCYTE PROLIFERATION; MAP3K3 GENE; MMP12 GENE; MOGAT3 GENE; MSX2 GENE; MVK GENE; NONHUMAN; NPC1L1 GENE; PDIA4 GENE; PDSS1 GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHGDH GENE; PLA2G1B GENE; PLA2G2A GENE; PLA2G4E GENE; PLA2G5 GENE; PLA2G6 GENE; PNLIPRP1 GENE; PRPF38B GENE; PSAT1 GENE; PSPH GENE; RBM25 GENE; RBMXL1 GENE; RRAS2 GENE; SCARB1 GENE; SCD GENE; SF3B1 GENE; SFRS9 GENE; SHMT2 GENE; SLC7A11 GENE; SNRNP40 GENE; SNRPE GENE; STT3A GENE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THOC1 GENE; ULBP1 GENE; UPREGULATION; ZSCAN2 GENE; CELL PROLIFERATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MONONUCLEAR CELL; VIROLOGY;

CHEMOKINE; CYTOKINE; MESSENGER RNA; TRANSCRIPTOME;

APOPTOSIS; CELL PROLIFERATION; CHEMOKINES; CYTOKINES; GENE EXPRESSION PROFILING; HIV INFECTIONS; HIV-1; HIV-2; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; RNA, MESSENGER; T-LYMPHOCYTES; TRANSCRIPTOME;

EID: 84958191271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147421     Document Type: Article

References (42)

1. Popper SJ, Sarr AD, Travers KU, Gueye-Ndiaye A, Mboup S, Essex ME, et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. The Journal of infectious diseases. 1999; 180(4):1116-21. doi: 10.1086/315010 PMID: 10479138.
2. Hilfinger JM, Clark N, Smith M, Robinson K, Markovitz DM. Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation. Journal of virology. 1993; 67(7):4448-53. PMID: 8510231; PubMed Central PMCID: PMC237823.
3. Koblavi-Deme S, Kestens L, Hanson D, Otten RA, Borget MY, Bile C, et al. Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Cote D'Ivoire. Aids. 2004; 18(3):413-9. PMID: 15090792.
4. Popper SJ, Sarr AD, Gueye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: Low virus production in vivo. Journal of virology. 2000; 74(3):1554-7. PMID: 10627569; PubMed Central PMCID: PMC111493.
5. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science. 2008; 319(5865):921-6. doi: 10.1126/science.1152725 PMID: 18187620.
6. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: A progress report on siRNA-based therapeutics. Nature reviews Drug discovery. 2007; 6(6):443-53. doi: 10.1038/nrd2310 PMID: 17541417.
7. Kameoka M, Kitagawa Y, Utachee P, Jinnopat P, Dhepakson P, Isarangkura-na-ayuthaya P, et al. Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes. Biochemical and biophysical research communications. 2007; 359(3):729-34. doi: 10.1016/j.bbrc.2007.05.173 PMID: 17560945.
8. Alimonti JB, Ball TB, Fowke KR. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. The Journal of general virology. 2003; 84(Pt 7):1649-61. PMID: 12810858.
9. Machuca A, Ding L, Taffs R, Lee S, Wood O, Hu J, et al. HIV type 2 primary isolates induce a lower degree of apoptosis "in vitro" compared with HIV type 1 primary isolates. AIDS research and human retroviruses. 2004; 20(5):507-12. doi: 10.1089/088922204323087750 PMID: 15186525.
10. Tan J, Wang X, Devadas K, Zhao J, Zhang P, Hewlett I. Some mechanisms of FLIP expression in inhibition of HIV-1 replication in Jurkat cells, CD4+ T cells and PBMCs. Journal of cellular physiology. 2013; 228(12):2305-13. doi: 10.1002/jcp.24397 PMID: 23696271.
11. Wang X, Gao Y, Tan J, Devadas K, Ragupathy V, Takeda K, et al. HIV-1 and HIV-2 infections induce autophagy in Jurkat and CD4+ T cells. Cellular signalling. 2012; 24(7):1414-9. doi: 10.1016/j.cellsig. 2012.02.016 PMID: 22406083.
12. Wang X, Viswanath R, Zhao J, Tang S, Hewlett I. Changes in the level of apoptosis-related proteins in Jurkat cells infected with HIV-1 versus HIV-2. Molecular and cellular biochemistry. 2010; 337(1-2):175-83. doi: 10.1007/s11010-009-0297-9 PMID: 19841866.
13. Wang X, Zhao J, Tang S, Lee S, Glazer RI, Hewlett I. c-FLIPL regulates PKC via AP-2 to inhibit Baxmediated apoptosis induced by HIV-1 gp120 in Jurkat cells. Molecular and cellular biochemistry. 2009; 330(1-2):23-9. doi: 10.1007/s11010-009-0096-3 PMID: 19363595.
14. Bosinger SE, Hosiawa KA, Cameron MJ, Persad D, Ran L, Xu L, et al. Gene expression profiling of host response in models of acute HIV infection. Journal of immunology. 2004; 173(11):6858-63. PMID: 15557180.
15. Huang T, Xu Z, Chen L, Cai YD, Kong X. Computational analysis of HIV-1 resistance based on gene expression profiles and the virus-host interaction network. PloS one. 2011; 6(3):e17291. doi: 10.1371/journal.pone.0017291 PMID: 21394196; PubMed Central PMCID: PMC3048858.
16. Imbeault M, Giguere K, Ouellet M, Tremblay MJ. Exon level transcriptomic profiling of HIV-1-infected CD4(+) T cells reveals virus-induced genes and host environment favorable for viral replication. PLoS pathogens. 2012; 8(8):e1002861. doi: 10.1371/journal.ppat.1002861 PMID: 22876188; PubMed Central PMCID: PMC3410884.
17. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell. 2008; 135(1):49-60. doi: 10.1016/j. cell.2008.07.032 PMID: 18854154; PubMed Central PMCID: PMC2628946.
18. Ockenhouse CF, Bernstein WB, Wang Z, Vahey MT. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. The Journal of infectious diseases. 2005; 191(12):2064-74. doi: 10.1086/430321 PMID: 15897992.
19. Salgado M, Lopez-Romero P, Callejas S, Lopez M, Labarga P, Dopazo A, et al. Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression. Virology. 2011; 411(1):103-12. doi: 10.1016/j.virol.2010.12.037 PMID: 21239032.
20. Van 't Wout AB, Lehrman GK, Mikheeva SA, O'Keeffe GC, Katze MG, Bumgarner RE, et al. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. Journal of virology. 2003; 77(2):1392-402. PMID: 12502855; PubMed Central PMCID: PMC140827.
21. Xu WW, Han MJ, Chen D, Chen L, Guo Y, Willden A, et al. Genome-wide search for the genes accountable for the induced resistance to HIV-1 infection in activated CD4+ T cells: Apparent transcriptional signatures, co-expression networks and possible cellular processes. BMC medical genomics. 2013; 6:15. doi: 10.1186/1755-8794-6-15 PMID: 23635305; PubMed Central PMCID: PMC3655860.
22. Gillis S, Scheid M, Watson J. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas. Journal of immunology. 1980; 125(6):2570-8. PMID: 6968790.
23. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate-a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met. 1995; 57(1):289-300. PMID: WOS:A1995QE45300017.
24. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010; 38(Web Server issue):W214-20. doi: 10.1093/nar/gkq537 PMID: 20576703; PubMed Central PMCID: PMC2896186.
25. Lee YS, Hwang SG, Kim JK, Park TH, Kim YR, Myeong HS, et al. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance. Cancer Genomics Proteomics. 2015; 12(3):153-66. PMID: 25977174.
26. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics. 2011; 27(3):431-2. doi: 10.1093/bioinformatics/btq675 PMID: 21149340; PubMed Central PMCID: PMC3031041.
27. Su G, Kuchinsky A, Morris JH, States DJ, Meng F. GLay: Community structure analysis of biological networks. Bioinformatics. 2010; 26(24):3135-7. doi: 10.1093/bioinformatics/btq596 PMID: 21123224; PubMed Central PMCID: PMC2995124.
28. Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, Yang S, et al. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. Journal of virology. 2007; 81(7):3477-86. doi: 10.1128/JVI.01552-06 PMID: 17251300; PubMed Central PMCID: PMC1866039.
29. Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: Energy metabolism and the T-cell response. Nature reviews Immunology. 2005; 5(11):844-52. doi: 10.1038/nri1710 PMID: 16239903.
30. Hollenbaugh JA, Munger J, Kim B. Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis. Virology. 2011; 415(2):153-9. doi: 10.1016/j.virol. 2011.04.007 PMID: 21565377; PubMed Central PMCID: PMC3107887.
31. Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. The Journal of experimental medicine. 2011; 208(7):1367-76. doi: 10.1084/jem.20110278 PMID: 21708926; PubMed Central PMCID: PMC3135370.
32. Rhoads MP, Lanigan J, Smith CJ, Lyall EG. Effect of specific ART drugs on lipid changes and the need for lipid management in children with HIV. Journal of acquired immune deficiency syndromes. 2011; 57 (5):404-12. doi: 10.1097/QAI.0b013e31821d33be PMID: 21499114.
33. Sievers M, Walker UA, Sevastianova K, Setzer B, Wagsater D, Eriksson P, et al. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy. The Journal of infectious diseases. 2009; 200 (2):252-62. doi: 10.1086/599986 PMID: 19519254.
34. Van 't Wout AB, Swain JV, Schindler M, Rao U, Pathmajeyan MS, Mullins JI, et al. Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. Journal of virology. 2005; 79(15):10053-8. doi: 10.1128/JVI.79.15.10053-10058.2005 PMID: 16014965; PubMed Central PMCID: PMC1181597.
35. Jones NP, Schulze A. Targeting cancer metabolism-aiming at a tumour's sweet-spot. Drug discovery today. 2012; 17(5-6):232-41. doi: 10.1016/j.drudis.2011.12.017 PMID: 22207221.
36. Palmer CS, Ostrowski M, Gouillou M, Tsai L, Yu D, Zhou J, et al. Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. Aids. 2013. doi: 10. 1097/QAD.0000000000000128 PMID: 24335483.
37. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011; 476(7360):346-50. doi: 10.1038/nature10350 PMID: 21760589; PubMed Central PMCID: PMC3353325.
38. Cui J, Chen Y, Chou WC, Sun L, Chen L, Suo J, et al. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic acids research. 2011; 39(4):1197-207. doi: 10.1093/nar/gkq960 PMID: 20965966; PubMed Central PMCID: PMC3045610.
39. Pincini A, Tornillo G, Orso F, Sciortino M, Bisaro B, Leal Mdel P, et al. Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells. Cell cycle. 2013; 12(15):2409-22. doi: 10.4161/cc.25415 PMID: 23839042; PubMed Central PMCID: PMC3841320.
40. Ye Y, Zhou Y, Zhang L, Chen Y, Lyu X, Cai L, et al. EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma. Biochemical and biophysical research communications. 2013; 436(1):19-24. doi: 10.1016/j.bbrc.2013.05.008 PMID: 23685147.
41. Jager S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, Clarke SC, et al. Global landscape of HIV-human protein complexes. Nature. 2012; 481(7381):365-70. doi: 10.1038/nature10719 PMID: 22190034; PubMed Central PMCID: PMC3310911.
42. Molina L, Grimaldi M, Robert-Hebmann V, Espert L, Varbanov M, Devaux C, et al. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope. Proteomics. 2007; 7(17):3116-30. doi: 10.1002/pmic.200700306 PMID: 17676665.